Stockscreener 앱 받기
1.15
0.86%
-0.01
시간 외 거래:
1.15
전일 마감가:
$1.16
열려 있는:
$1.19
하루 거래량:
58,006
Relative Volume:
0.71
시가총액:
$49.49M
수익:
-
순이익/손실:
$-13.06M
주가수익비율:
-3.2204
EPS:
-0.3571
순현금흐름:
$-1.79M
1주 성능:
+0.88%
1개월 성능:
-27.22%
6개월 성능:
-38.83%
1년 성능:
+10.58%
1일 변동 폭
$1.04
$1.19
1주일 범위
$1.04
$1.19
52주 변동 폭
$0.78
$3.15
Estrella Immunopharma Inc Stock (ESLA) Company Profile
명칭
Estrella Immunopharma Inc
전화
(510) 318-9098
주소
5858 HORTON STREET, SUITE 370, EMERYVILLE
Compare ESLA vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ESLA
Estrella Immunopharma Inc
|
1.15 | 49.92M | 0 | -13.06M | -1.79M | -0.3571 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Estrella Immunopharma Inc 주식(ESLA)의 최신 뉴스
Estrella Immunopharma (ESLA) Q1 2026 Earnings: Wider-Than-Expected Loss Triggers Modest Stock GainLow Growth Earnings - Newser
Estrella Immunopharma (ESLA) Q1 2026 Earnings Slump: EPS Falls Short of $-0.18 TargetHigh Interest Stocks - Newser
Estrella Immunopharma (ESLA) Q1 2026 Earnings Miss by Significant: Key TakeawaysEPS Growth Rate - Newser
Estrella Immunopharma, Inc. 2026 Q1 Financial Report: Key Financials, Related Party Transactions, and R&D Update - Minichart
Estrella Immunopharma, Inc. 1Q 2026: Net income $(2.29M), EPS $(0.05) — 10-Q Summary - TradingView
Estrella Immunopharma (ESLA) Stock Analysis: Falls -6.22%, Watching $1.07 2026-05-15Popular Market Picks - newser.com
[SCHEDULE 13G] Estrella Immunopharma, Inc. Passive Investment Disclosure (>5%) - Stock Titan
[NT 10-Q] Estrella Immunopharma, Inc. SEC Filing - Stock Titan
TradingKey - TradingKey
The quiet positioning of Estrella (ESLAW) nobody discusses (Moonwalks) 2026-05-08Bullish Pattern - newser.com
Estrella Immunopharma (ESLA) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat
Estrella Immunopharma to Participate in the D. Boral Capital Global Conference - BioSpace
10-K/A: Annual report (Amendment) - Moomoo
Is Estrella (ESLAW) stock a safe investment |Hot Momentum Watchlist - Newser
Eureka-led Estrella (NASDAQ: ESLA) details 59.3% control and board pay - Stock Titan
Estrella Immunopharma CFO Xu Jiandong buys $2,594 in stock - Investing.com
Estrella Immunopharma CFO Xu Jiandong buys $2,594 in stock By Investing.com - Investing.com Canada
Estrella Immunopharma (ESLA) CFO boosts stake with small share buys - Stock Titan
ESLA Estrella Immunopharma falls 3.92% after Q1 2026 EPS misses analyst forecasts by a wide 90.6% margin.Growth Phase - newser.com
Is Estrella (ESLAW) stock a good option for investors |High Volatility - newser.com
Estrella Immunopharma (ESLA) Stock: Changing Trend? (Institutional Selling) 2026-04-27Trending Picks - Newser
Short Interest in Estrella Immunopharma, Inc. (NASDAQ:ESLA) Declines By 57.6% - MarketBeat
OneIM Acquisition Corp. (OIM) - Minichart
Estrella Immunopharma (ESLA) Management Strategy | Q1 2026: Below ExpectationsStrong Sell - Cổng thông tin điện tử tỉnh Tây Ninh
Robinson Opportunistic Income Fund's Estrella Immunopharma Inc(ESLAW) Holding History - GuruFocus
Estrella Immunopharma (ESLA) Stock Dividend Yield (Drifts Lower) 2026-04-20Most Discussed Stocks - Cổng thông tin điện tử tỉnh Lào Cai
ESLA (Estrella Immunopharma Inc.) reports wider than expected Q1 2026 EPS loss but shares rise 13 percent in regular trading.Revenue Growth - Newser
Estrella Immunopharma, Inc. (ESLAW) - Minichart
Estrella Immunopharma (ESLA) Stock: Increase Exposure? (Dips) 2026-04-16Trending Volume Leaders - Cổng thông tin điện tử Tỉnh Sơn La
Sectors Review: Should you buy the dip on Estrella Immunopharma Inc2026 Retail Activity & Daily Profit Maximizing Tips - baoquankhu1.vn
Published on: 2026-04-09 23:33:21 - baoquankhu1.vn
Quarterly Recap: Is Estrella Immunopharma Inc stock a good pick for beginnersQuarterly Investment Review & Safe Capital Growth Stock Tips - baoquankhu1.vn
Is Estrella Immunopharma (ESLA) Stock a Buy Now | Price at $1.88, Up 9.30%Resistance Breakout - Newser
12 Health Care Stocks Moving In Tuesday's Intraday Session - Sahm
Aug Drivers: Will Estrella Immunopharma Inc benefit from current market trendsPortfolio Performance Report & Verified Technical Signals - baoquankhu1.vn
Should I Buy Estrella (ESLAW) Stock Today | Price at $0.09, Up 20.29%Buy Zone Stocks - Newser
ESLA Should I Buy - Intellectia AI
Aug Outlook: Should you buy the dip on Estrella Immunopharma Inc2026 Analyst Calls & Community Consensus Trade Alerts - baoquankhu1.vn
Estrella Immunopharma ESLA US - Smartkarma
Insider Sell: Is Estrella Immunopharma Inc stock technically oversold2026 Fed Impact & Verified Short-Term Plans - baoquankhu1.vn
Silexion Granted Approval to Launch Human Trials That Could Redefine the Future of Cancer Treatment - Benzinga
Top Curanex Pharmaceuticals (CURX) Competitors 2026 - MarketBeat
Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research - BioSpace
Masco Corporation Announces Date for Earnings Release and Conference Call for 2026 First Quarter - weeklyvoice.com
If You Invested $1,000 in Estrella Immunopharma (ESLA) - Stock Titan
Estrella Immunopharma, Inc.: Fundamental Analysis and Financial Ratings | ESLA | US2975841048 - MarketScreener
Estrella Immunopharma: Advancing Next-Generation T-Cell Therapies for Cancer and Autoimmune Diseases - Minichart
Estrella 10-K: Net loss widens to $13.1M in 2025; cash $1.4M, working capital deficit $11.9M - TradingView
ESLA PE Ratio & Valuation, Is ESLA Overvalued - Intellectia AI
EB103 lymphoma trial data and pipeline update from Estrella (NASDAQ: ESLA) - Stock Titan
Estrella Immunopharma Inc (ESLA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Estrella Immunopharma Inc 주식 (ESLA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Xu Jiandong | Chief Financial Officer |
Sep 22 '25 |
Buy |
1.16 |
1,000 |
1,160 |
16,700 |
| Xu Jiandong | Chief Financial Officer |
Sep 11 '25 |
Buy |
1.04 |
100 |
104 |
264,588 |
0.98%
0.12%
자본화:
|
볼륨(24시간):